Recombinant Parvovirus B19 VLP VP2 produced in Sf9 insect cell is a glycosylated, polypeptide chain having a calculated molecular mass of 60839 Dalton.
SARS-CoV-2 virus-like particles are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Spike protein (S) and Envelope protein (E). VLPs are produced in HEK293 cells.
Norovirus GI.1 VLP protein expressed in baculovirus infected Trichoplusia ni cells.
Recombinant Parvovirus B19 VLP VP1/VP2 protein consists of VP2 conformational epitopes and VP1 228 a.a.- 781 a.a. expressed in baculovirus infected Sf9 cells.
Recombinant Dengue Virus serotype 3 (Sri Lanka D3/H/IMTSSA-SRI/2000/1266) virus-like particles (VLP) consisting of Envelope, pre-Membrane and Membrane protein produced in HEK293 cells. The C terminal 20% of the Dengue Virus Envelope protein was replaced by the corresponding Japanese Encephalitis Virus SA-14 sequence (Envelope protein 399 a.a - 492 a.a)....
Norovirus GII.4 VLP protein expressed in baculovirus infected Trichoplusia ni cells.
Recombinant Dengue Virus serotype 2 VLP protein consists of E, M and preM proteins (AAP06254.1) with substituting the C terminus 20% with the corresponding Japanese encephalitis virus (strain SA-14) sequence (Envelope protein E 397 a.a.- 495 a.a) with His tag expressed in 293 cells.
Recombinant Parvovirus B19 VLP VP1/VP2 Co-Capsid containing B19 capsid proteins VP1 (81 kDa) and VP2 (61 kDa) produced in SF9 insect cell .
Recombinant Parvovirus B19 VLP VP1 contains 227 amino acids from the N-terminus of VP1 protein sequence produced in Escherichia coli.